Basic & Clinical Medicine ›› 2016, Vol. 36 ›› Issue (7): 896-901.

Previous Articles     Next Articles

Naringenin ameliorates kidney injury by inhibitiing TGF-β1/smad signaling pathway in diabetic nephropathy rats

  

  • Received:2015-12-21 Revised:2016-03-25 Online:2016-07-05 Published:2016-06-22
  • Contact: 易红 E-mail:zhangzheng92@163.com

Abstract: Objective To explore the protectory effects of naringenin (NAR) on kidney as well as its effects on TGF-β1/smad signaling pathway in diabetic nephropathy rats. Methods Experimental rats were randomly assigned into diabetic nephropathy group and naringenin group. After rats were treated with naringenin for 6 weeks, the 24 h-urinary protein (24 h-UP), Creatinine clearance rate (Ccr) and kidney index (KI) were detected. Glomerular pathological changes and glomerular area(GA) were observed by HE-straning. Type Ⅳ collagen(Col4)、fibronectin(FN) were detected by real-time PCR and Western blot. TGF-β1,smad7,t-smad2 and p-smad2 were detected by Western blot. Results Compared with CON group, the 24 h-UP (P <0.01), KI (P <0.01) and GA (P <0.05) were increased, whereas Ccr (P <0.01) was declined in DN group, the mRNA and protein of Col4 and FN were increased, the protein of TGF-β1 and p-smad2 were increased and smad7 was decreased. Naringenin treatment could significantly attenuated the renal lesion, inhibited the expression of Col4,FN,TGF-β1 and p-smad2, improved the expression of smad7. Conclusion Naringenin ameliorates renal function, has marked protectory effects on kidneys in diabetic nephropathy, possibly through inhibited the activation of TGF-β1/smad and reduced the deposition of ECM proteins.

Key words: naringenin, ECM, TGF-β1/Smad signaling, diabetic nephropathy

CLC Number: